Identification
Properties
Safety Data
Specifications & Other Information
Links
Identification
CAS Number
1310726-60-3
Name
Upadacitinib
Synonyms
(
3S,
4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluorethyl)-1-pyrrolidincarboxamid [German] [
ACD/
IUPAC Name] (
3S,
4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide [
ACD/
IUPAC Name] (
3S,
4R)-3-Éthyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroéthyl)-1-pyrrolidinecarboxamide [French] [
ACD/
IUPAC Name] (
3S,
4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide 10209 1310726-60-3 [
RN] 1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (
3S,
4R)- [
ACD/Index Name]
4RA0KN46E0 ABT-494 UNII :
4RA0KN46E0 UNII-4RA0KN46E0 upadacitinib [
INN] [
USAN] upadacitinib [Spanish] [
INN] upadacitinib [French] [
INN] upadacitinibum [Latin] [
INN] упадацитиниб [Russian] [
INN] 乌帕替尼 [Chinese] [
INN]
MFCD30502663 SMILES
CC[C@@H]
1CN(C[C@@H]1c2cnc3n2c4cc[nH]c4nc3)C(=O)
NCC(F)(F)F
StdInChI
InChI=
1S/
C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,
21H,2,7-9H2,
1H3,(H,24,27)/t10-,11+/m1/s1
StdInChIKey
WYQFJHHDOKWSHR-MNOVXSKESA-N Molecular Formula
C17H19F3N6O Molecular Weight
380.368
MDL Number
MFCD30502663 Properties
Appearance
Yellow to off-white powder
Safety Data
WGK Germany
3
Specifications and Other Information of Our Upadacitinib CAS 1310726-60-3
Standard
Enterprise standard
Identification Methods
HNMR,
HPLC Purity
≥99%
Ee By HPLC
≥99%
Heavy Metals
≤0.002%
Loss on Drying
≤0.5%
Any individual impurity
≤0.5%
Total Impurities
≤1.0%
Package
According to customer requirements to packaging
Storage
Under the room temperature and away from light
Application
Upadacitinib is a potent and selective
JAK inhibitor for the treatment of rheumatoid arthritis.
General View of Documents
Links
This product is developed by our R
&D company Caming Pharmaceutical Ltd(
http://www.caming.com/), and here is the corresponding link
http://www.caming.com/upadacitinib-cas-1310726-60-3/
Quick Inquiry
Fill out our inquiry form and one of our experts will be in touch with you shortly.